GGrantIndex
← Leaderboards

Thalia Papayannopoulou

University Of Washington

$16,580,758
Attributed
$16,879,138
Total exposure
13
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200520
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20

Funding mix

By agency

NIH$16,879,138 · 13

By mechanism

R01$13,969,901 · 7
T32$1,592,720 · 1
P01$1,270,517 · 2
R13$46,000 · 2
M01$0 · 1

Top collaborators

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsIn VivoStem CellsTransplantationHematopoiesisIn VitroGene ExpressionResponseIntegrinsStemEngraftmentBone MarrowMediatingAntibodiesGeneticHematopoietic Stem CellsSiteGenetically Modified AnimalsPhenotypeGenesBone Marrow TransplantationGene TargetingPatternBase

Grant awards (58)

New Chromatin Insulators and Enhancers for Gene Therapy of the Hemoglobinopathies$580,093
R01 · FY2020 · HL · contact PI
New Chromatin Insulators and Enhancers for Gene Therapy of the Hemoglobinopathies$580,093
R01 · FY2019 · HL · contact PI
New Chromatin Insulators and Enhancers for Gene Therapy of the Hemoglobinopathies$579,627
R01 · FY2018 · HL · contact PI
Universal Donor Megakaryocytes$398,818
R01 · FY2018 · HL · contact PI
GENOME EDITING FOR DEVELOPING A TREATMENT FOR BETA GLOBIN DISORDERS$336,038
R01 · FY2018 · DK · contact PI
New Chromatin Insulators and Enhancers for Gene Therapy of the Hemoglobinopathies$577,761
R01 · FY2017 · HL
Universal Donor Megakaryocytes$398,818
R01 · FY2017 · HL · contact PI
GENOME EDITING FOR DEVELOPING A TREATMENT FOR BETA GLOBIN DISORDERS$336,038
R01 · FY2017 · DK · contact PI
GENOME EDITING FOR DEVELOPING A TREATMENT FOR BETA GLOBIN DISORDERS$336,038
R01 · FY2016 · DK · contact PI
GENOME EDITING FOR DEVELOPING A TREATMENT FOR BETA GLOBIN DISORDERS$336,038
R01 · FY2015 · DK · contact PI
Beta 1 integrins in erythropoiesis$336,038
R01 · FY2014 · DK · contact PI
GENOME EDITING FOR DEVELOPING A TREATMENT FOR BETA GLOBIN DISORDERS$336,038
R01 · FY2014 · DK · contact PI
Strategies to promote Engraftment of Genetically Modified Hemopoietic$70,817
P01 · FY2014 · HL · contact PI
Beta 1 integrins in erythropoiesis$324,277
R01 · FY2013 · DK · contact PI
Strategies to promote Engraftment of Genetically Modified Hemopoietic$66,674
P01 · FY2013 · HL · contact PI
Beta 1 integrins in erythropoiesis$336,038
R01 · FY2012 · DK · contact PI
Strategies to promote Engraftment of Genetically Modified Hemopoietic$70,579
P01 · FY2012 · HL · contact PI
Homing Determinants in Hemopoietic Stem/Progenitor Cells$390,000
R01 · FY2011 · HL · contact PI
Beta 1 integrins in erythropoiesis$335,222
R01 · FY2011 · DK · contact PI
Strategies to promote Engraftment of Genetically Modified Hemopoietic$71,948
P01 · FY2011 · HL · contact PI
Homing Determinants in Hemopoietic Stem/Progenitor Cells$390,000
R01 · FY2010 · HL · contact PI
Strategies to promote Engraftment of Genetically Modified Hemopoietic$71,475
P01 · FY2010 · HL · contact PI
ISEH Annual Meeting: Young Investigator Programs$19,000
R13 · FY2010 · DK
Homing Determinants in Hemopoietic Stem/Progenitor Cells$390,000
R01 · FY2009 · HL · contact PI
Biological Properties and Regulation of Stem Cells$377,476
R01 · FY2009 · HL · contact PI
ISEH Annual Meeting: Young Investigator Programs$27,000
R13 · FY2009 · DK · contact PI
Homing Determinants in Hemopoietic Stem/Progenitor Cells$390,000
R01 · FY2008 · HL · contact PI
Biological Properties and Regulation of Stem Cells$377,476
R01 · FY2008 · HL · contact PI
CORE--NOD/SCID MOUSE$95,527
P01 · FY2008 · HL · contact PI
Biological Properties and Regulation of Stem Cells$377,476
R01 · FY2007 · HL · contact PI
CORE--NOD/SCID MOUSE$110,958
P01 · FY2007 · HL · contact PI
Biological Properties and Regulation of Stem Cells$388,750
R01 · FY2006 · HL · contact PI
Homing Determinants in Hemopoietic Stem/Progenitor Cells$333,085
R01 · FY2006 · HL · contact PI
CORE--NOD/SCID MOUSE$106,678
P01 · FY2006 · HL · contact PI
Homing Determinants in Hemopoietic Stem/Progenitor Cells$341,100
R01 · FY2005 · HL
CORE--NOD/SCID MOUSE$104,040
P01 · FY2005 · HL
BIOLOGICAL PROPERTIES AND REGULATION OF STEM CELLS$380,000
R01 · FY2004 · HL
Homing Determinants in Hemopoietic Stem/Progenitor Cells$341,100
R01 · FY2004 · HL
Research Training in Hematology$324,841
T32 · FY2004 · HL
CORE--NOD/SCID MOUSE$101,132
P01 · FY2004 · HL
BIOLOGICAL PROPERTIES AND REGULATION OF STEM CELLS$380,000
R01 · FY2003 · HL
RESEARCH TRAINING IN HEMATOLOGY$351,331
T32 · FY2003 · HL
Homing Determinants in Hemopoietic Stem/Progenitor Cells$341,100
R01 · FY2003 · HL
GLOBIN SWITCHING AND ERYTHROID DIFFERENTIATION$456,739
R01 · FY2002 · DK
BIOLOGICAL PROPERTIES AND REGULATION OF STEM CELLS$380,000
R01 · FY2002 · HL
RESEARCH TRAINING IN HEMATOLOGY$339,822
T32 · FY2002 · HL
Core--SCID/NOD mouse$88,647
P01 · FY2002 · HL
EFFECTS OF HYDROXYUREA IN SICKLE CELL DISEASE$0
M01 · FY2002 · RR
GLOBIN SWITCHING AND ERYTHROID DIFFERENTIATION$445,121
R01 · FY2001 · DK
BIOLOGICAL PROPERTIES AND REGULATION OF STEM CELLS$380,000
R01 · FY2001 · HL
RESEARCH TRAINING IN HEMATOLOGY$273,628
T32 · FY2001 · HL
Core--SCID/NOD mouse$88,647
P01 · FY2001 · HL
EFFECTS OF HYDROXYUREA IN SICKLE CELL DISEASE$0
M01 · FY2001 · RR
GLOBIN SWITCHING AND ERYTHROID DIFFERENTIATION$433,843
R01 · FY2000 · DK
RESEARCH TRAINING IN HEMATOLOGY$303,098
T32 · FY2000 · HL
BIOLOGICAL PROPERTIES AND REGULATION OF STEM CEL$297,180
R01 · FY2000 · HL
HOMING DETERMINANTS--HEMATOPOIETIC STEM/PROGENITOR CELLS$252,480
R01 · FY2000 · HL
Core--SCID/NOD mouse$223,395
P01 · FY2000 · HL